Alkeon Capital Management LLC Sarepta Therapeutics, Inc. Transaction History

Alkeon Capital Management LLC

$58.2 Billion
Q3 2024

A detailed history of Alkeon Capital Management LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Alkeon Capital Management LLC holds 633,845 shares of SRPT stock, worth $72.4 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

633,845

Previous 558,845 13.42%

Holding current value

$72.4 Million

Previous $88.3 Million 10.34%

% of portfolio

0.14%

Previous 0.15%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$124.33 - $156.75 $9.32 Million - $11.8 Million	75,000 Added 13.42%	633,845 $79.2 Million
Q2 2024 Aug 13, 2024	BUY	$113.33 - $163.85 $11.3 Million - $16.4 Million	100,000 Added 21.79%	558,845 $88.3 Million
Q1 2024 May 14, 2024	BUY	$93.7 - $141.53 $9.37 Million - $14.2 Million	100,000 Added 27.87%	458,845 $59.4 Million
Q4 2023 Feb 13, 2024	SELL	$67.31 - $124.76 $6.73 Million - $12.5 Million	-100,000 Reduced 21.79%	358,845 $34.6 Million
Q3 2023 Nov 13, 2023	SELL	$102.5 - $123.59 $5.13 Million - $6.18 Million	-50,000 Reduced 9.83%	458,845 $55.6 Million
Q2 2023 Aug 11, 2023	SELL	$106.4 - $157.19 $21.7 Million - $32.1 Million	-203,989 Reduced 28.62%	508,845 $58.3 Million
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $4.61 Million - $6.12 Million	39,222 Added 5.82%	712,834 $98.2 Million
Q4 2022 Feb 13, 2023	SELL	$100.86 - $132.13 $56.3 Million - $73.7 Million	-557,784 Reduced 45.3%	673,612 $87.3 Million
Q3 2022 Nov 10, 2022	BUY	$75.71 - $119.24 $5.68 Million - $8.94 Million	75,000 Added 6.49%	1,231,396 $136 Million
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $1.22 Million - $1.72 Million	-19,400 Reduced 1.65%	1,156,396 $86.7 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $5.1 Million - $7.31 Million	80,796 Added 7.38%	1,175,796 $91.9 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $77.7 Million - $100 Million	1,006,000 Added 1130.34%	1,095,000 $98.6 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $5.87 Million - $8.23 Million	89,000 New	89,000 $8.23 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $1.65 Million - $2.63 Million	-20,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $1.53 Million - $2.71 Million	20,000 New	20,000 $2.58 Million

Others Institutions Holding SRPT

# of Institutions

531

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.

Account

Alkeon Capital Management LLC Sarepta Therapeutics, Inc. Transaction History